Proshares Ultra Nasd BiotechBIBETF
13F holders, Q3 2025 (September 30)19holders +2
5new positions
4sold out
1famous investor
$49.36avg. 13F price*
At the end of Q3 2025, 19 institutions reported holding Proshares Ultra Nasd Biotech (BIB) in their 13F filings, up 2 from Q2 2025. 5 opened new positions and 4 sold out. The largest holders were Susquehanna International Group, LLP ($840K), Chase Investment Counsel Corp. ($534K) and Capital Investment Advisors, LLC ($363K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Proshares Ultra Nasd Biotech
- CUSIP
- 74347R214
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 5 | $635K |
| Exits | 4 | $394K |
All 13F filers, Q2 2025 → Q3 2025: 27,272 shares bought and 11,043 shares sold, net +16,229 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 19 holders
"% of holder's portfolio" is BIB's weight in each manager's 13F, not the share of Proshares Ultra Nasd Biotech the manager owns.